MoneyWorks4Me

Indrayani Biotech informs about disclosure

20 Sep 2025 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, BSE has issued In-principle approval vide Ref: LOD/RIGHT/TT/FIP/920/2025-26 dated 19th September, 2025 for the proposed Right Issue; Indrayani Biotech has informed that the In-principle approval letter received from the Stock Exchange BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Grasim Industries 3188.00
DCM Shriram 984.20
3M India 34722.30
Hindustan Foods 617.45
Balmer Lawrie & Co 166.15
View more..